z-logo
open-access-imgOpen Access
MP83-01 ELECTROMOTIVE DRUG ADMINISTRATION (EMDA) OF MITOMYCIN C AS FIRST LINE SALVAGE THERAPY IN HIGH RISK “BCG-FAILURE” NON MUSCLE INVASIVE BLADDER CANCER: 3 YEARS FOLLOWUP OUTCOMES
Author(s) -
L. Di Gianfrancesco,
Marco Racioppi,
Mauro Ragonese,
Giuseppe Palermo,
Niccolò Lenci,
Emilio Sacco,
Pierfrancesco Bassi
Publication year - 2018
Publication title -
the journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.402
H-Index - 256
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2018.02.2749
Subject(s) - medicine , bladder cancer , mitomycin c , cystectomy , surgery , cancer , urology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom